Navigation Links
Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
Date:8/1/2008

LITTLE FALLS, N.J., Aug. 1 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced management changes at its Crosstex International, Inc. subsidiary, effective today. As planned, Richard Allen Orofino, President and a former owner of Crosstex, retired effective today after over 50 years with Crosstex, including 3 years following Cantel's acquisition of the company. Gary Steinberg and Mitchell Steinberg, also former owners of Crosstex who have served as Executive Vice-Presidents of Crosstex, have been promoted and will now lead the company. Gary Steinberg has been appointed Chief Executive Officer of Crosstex with full day-to-day responsibilities. Mitchell Steinberg has been appointed President and will focus primarily on the sales and marketing efforts. Mr. Orofino has agreed to serve in a consulting capacity following his retirement.

Andrew A. Krakauer, President of Cantel, said, "Richard has been a great leader for many years at Crosstex, and I would like to particularly thank him for his efforts over the last 3 years as Crosstex was integrated into the Cantel family of companies. His counsel and experience were key factors in the great success we have had with this acquisition. I have great confidence in Gary's and Mitchell's ability to continue to lead Crosstex. They have been partners with Richard for many years and greatly responsible for making Crosstex the leading healthcare disposables company that it is today."

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.

Contact: Andrew A. Krakauer Richard E. Moyer

President Cameron Associates, Inc.

Cantel Medical Corp. richard@cameronassoc.com

Phone: (973) 890-7220 Phone: (212) 554-5466


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
2. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
3. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
4. BioMS Medical to present at BMO Healthcare Conference
5. DeviceSpace(TM) to Host Medical Device and Diagnostics Career Fair in Minneapolis
6. Inverness Medical Innovations Announces Second Quarter 2008 Results
7. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
8. Roche and Response Biomedical Corporation Aim to Reduce Vein-to-Brain Time with New Point-of-Care Cardiac Tests
9. Arcadia Radiology Medical Group Chooses AMICAS
10. VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
11. China Medical Technologies Adjusts Conversion Rate of Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... , March 22, 2017  UBM and the ... announce their extended partnership and the third annual Massachusetts ... by the 21 st Annual MassMEDIC Conference ... place May 3-4, 2017. MassMEDIC ... Association (ADVAMED) President and CEO, Scott Whitaker ...
(Date:3/22/2017)... 22, 2017 The global chronic ... research report by Transparency Market Research (TMR). The top ... and AbbVie Inc., accounted for a share of only ... in this market are focusing aggressively on mergers, acquisitions, ... is likely to lead to market consolidation in the ...
Breaking Biology Technology:
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber ... announced it has led a $3.5 million investment in  ... platform. Strategic Cyber Ventures is DC based and is ... Hank Thomas . Ron Gula , also ... Ventures, also participated in this series A round of ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):